MedPath

Scibase AB

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of Nevisense as Support Tool for the Diagnose of Keratinocyte Skin Cancer

Not Applicable
Recruiting
Conditions
Keratinocyte Skin Cancer
Interventions
Device: Nevisense
First Posted Date
2023-10-03
Last Posted Date
2024-12-11
Lead Sponsor
SciBase AB
Target Recruit Count
150
Registration Number
NCT06064019
Locations
🇩🇪

CentroDerm, Wuppertal, Germany

Clinical Utility of Electrical Impedance Spectroscopy

Not Applicable
Conditions
Focus of Study: Patients With Suspicion of Melanoma
First Posted Date
2019-11-13
Last Posted Date
2019-11-13
Lead Sponsor
SciBase AB
Target Recruit Count
180
Registration Number
NCT04161742

SciBase International Melanoma Pivotal Study

Not Applicable
Completed
Conditions
Malignant Melanoma
Interventions
Device: SciBase III Electrical Impedance Spectrometer
First Posted Date
2010-02-26
Last Posted Date
2013-12-30
Lead Sponsor
SciBase AB
Target Recruit Count
1951
Registration Number
NCT01077050
Locations
🇺🇸

University of Arizona, Tucson, Arizona, United States

🇸🇪

Sahlgrenska University Hospital, Gothenburg, Sweden

International Melanoma Algorithm Training Study - IMATS

Not Applicable
Completed
Conditions
Malignant Melanoma
First Posted Date
2009-08-26
Last Posted Date
2010-08-11
Lead Sponsor
SciBase AB
Target Recruit Count
1800
Registration Number
NCT00966173
Locations
🇸🇪

Sahlgrenska University Hospital, Dpt. of Dermatology, Gothenburg, Sweden

© Copyright 2025. All Rights Reserved by MedPath